ROBIN MILLER: Open Payments
NPI 1316906159 · MOORESTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 17 payments from 8 companies in 2025. Trend: 2023 $1,582 · 2024 $304 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $152 |
| ABBVIE INC. | 4 | $150 |
| Celltrion USA Inc. | 1 | $123 |
| Ardelyx, Inc. | 4 | $86 |
| Janssen Biotech, Inc. | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Ferring Pharmaceuticals Inc. | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $18 |
Products named: XIFAXAN, ZYMFENTRA, IBSRELA, TREMFYA, DUPIXENT, REBYOTA, LINZESS, REZDIFFRA.
Industry payments across NJ — which companies pay providers there.
